The Prevention Gap: Why PrEP in New York City Is Reaching the Already-Resourced and Missing Everyone Else

When the FDA approved tenofovir disoproxil fumarate and emtricitabine as pre-exposure prophylaxis in 2012, public health advocates called it a turning point. A daily pill that could reduce the risk of HIV acquisition by more than 99 percent represented, on paper, one of the most powerful prevention tools in the history of the epidemic. Twelve years later, in a city that has made Ending the Epidemic a formal policy goal, PrEP remains startlingly out of reach for the New Yorkers who need it most.

The reasons are not mysterious. They are structural, persistent, and — critically — the product of policy choices that could be unmade.

Who Is Actually on PrEP in New York

New York State's Ending the Epidemic initiative has tracked PrEP uptake since its launch, and the data reveal a pattern that is both predictable and damning. White gay men in Manhattan and parts of Brooklyn account for a disproportionate share of PrEP users relative to their HIV risk profile. Meanwhile, Black and Latino men who have sex with men — who bear a dramatically higher burden of new HIV diagnoses — are significantly underrepresented in PrEP uptake figures.

Women, particularly Black women in the Bronx and Central Brooklyn, remain among the most underserved populations despite facing real and documented HIV risk. Transgender individuals, undocumented immigrants, people who inject drugs, and low-income New Yorkers of all backgrounds continue to face access barriers that effectively exclude them from the prevention landscape.

A 2022 analysis published by the New York City Department of Health and Mental Hygiene found that PrEP coverage — defined as the proportion of people with clinical indications for PrEP who are actually prescribed it — was highest in Manhattan and lowest in the Bronx and Staten Island. The boroughs with the highest new HIV diagnosis rates were the same boroughs with the lowest PrEP access rates. That is not a coincidence. It is the geography of inequality made visible in epidemiological data.

The Insurance Labyrinth

For New Yorkers with comprehensive private insurance, initiating PrEP is, relative to the process facing uninsured individuals, straightforward. A prescription, a lab panel, quarterly monitoring visits — these are covered, manageable, and largely invisible as financial burdens.

For those without insurance, or with Medicaid plans that impose prior authorization requirements, the pathway is considerably more fraught. Gilead's patient assistance program, Ready, Set, PrEP, and the federal program that provides PrEP medications at no cost exist — but awareness of these programs is uneven, enrollment processes can be cumbersome, and they do not cover the clinical visits, laboratory monitoring, and follow-up care that are medically necessary to use PrEP safely.

"The pill is not the whole picture," explains a nurse practitioner at a community health center in the South Bronx. "You need labs every three months. You need STI screening. You need a provider relationship. If any one of those pieces is missing, PrEP becomes something people start and then stop — which creates its own set of problems."

Partial access is not the same as access. And for many low-income New Yorkers, the cost of supporting services — even when the medication itself is subsidized — is sufficient to interrupt or prevent sustained use.

Immigration Status as a Prevention Barrier

For undocumented New Yorkers, the barriers to PrEP extend well beyond cost. Fear of engaging with healthcare systems that may interact with immigration enforcement infrastructure keeps many people from seeking care of any kind — preventive or otherwise. The erosion of public charge rule protections under prior federal administrations, and ongoing uncertainty about their durability, has created a climate in which some immigrants rationally calculate that seeking PrEP is a risk they cannot afford to take.

Community health workers at several organizations serving immigrant communities in Queens and the Bronx describe patients who understand PrEP, want PrEP, and do not access PrEP because the cost of being seen — in every sense of that phrase — feels too high.

"We have people who know exactly what PrEP is and exactly why they need it," says one outreach worker at a Jackson Heights-based organization. "And they won't come in. Not because they don't trust us. Because they don't trust the system around us. And honestly? Given what they've seen, that's not irrational."

The Community Infrastructure Filling the Gaps

In neighborhoods where the formal healthcare system has failed to deliver PrEP equitably, community-based organizations have stepped into the breach — often without adequate funding and always without adequate recognition.

Organizations across the city have developed PrEP navigation programs that pair individuals with trained advocates who help them identify coverage options, complete enrollment paperwork, and maintain the ongoing monitoring required for safe use. Some have embedded PrEP services within existing community spaces — barbershops, churches, syringe service programs — to reduce the friction of access for people who would not otherwise walk into a clinic.

These models are effective. They are also chronically underfunded, dependent on short-term grant cycles, and stretched across caseloads that grow faster than their capacity to serve them.

"We're doing the work the system should be doing," says the director of a PrEP navigation program based in central Brooklyn. "And we're doing it on a fraction of the resources. That's not sustainable. It's not equitable. And it lets the system off the hook."

What Genuine Democratization Would Require

Making PrEP genuinely accessible to all New Yorkers — not just those with the insurance, documentation, proximity, and confidence to navigate existing systems — requires intervention at several levels simultaneously.

First, clinical infrastructure must be expanded in the boroughs and neighborhoods where need is highest and access is lowest. This means funding HIV prevention services in the Bronx, Staten Island, and the outer reaches of Queens and Brooklyn with the same intensity applied to Manhattan's already-resourced health corridors.

Second, the monitoring and support services surrounding PrEP must be funded as part of the prevention package — not treated as optional extras that patients must find and finance independently.

Third, immigration-inclusive healthcare policy must be strengthened and protected, so that undocumented New Yorkers can access prevention services without fear of systemic consequences.

And fourth, community organizations that have built trust in underserved communities must be funded as primary partners in the prevention infrastructure — not as afterthoughts or stopgaps.

PrEP works. The science is not in question. What is in question is whether New York City is willing to ensure that the people most at risk of HIV are the ones most reliably reached by the tools designed to protect them. That is a question about values. And the current answer — reflected in the data, in the geography, in the faces of who is and is not on PrEP — is not one this city should be willing to accept.